Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19
Abstract Background We investigated the feasibility of two biomarkers of endothelial damage (Syndecan-1 and thrombomodulin) in coronavirus disease 2019 (COVID-19), and their association with inflammation, coagulopathy, and mortality. Methods The records of 49 COVID-19 patients who were admitted to a...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
BMC
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e4b741f2f0814af9b22c301b2190d647 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:e4b741f2f0814af9b22c301b2190d647 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:e4b741f2f0814af9b22c301b2190d6472021-12-05T12:08:03ZSyndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-1910.1186/s10020-021-00412-11076-15511528-3658https://doaj.org/article/e4b741f2f0814af9b22c301b2190d6472021-12-01T00:00:00Zhttps://doi.org/10.1186/s10020-021-00412-1https://doaj.org/toc/1076-1551https://doaj.org/toc/1528-3658Abstract Background We investigated the feasibility of two biomarkers of endothelial damage (Syndecan-1 and thrombomodulin) in coronavirus disease 2019 (COVID-19), and their association with inflammation, coagulopathy, and mortality. Methods The records of 49 COVID-19 patients who were admitted to an intensive care unit (ICU) in Wuhan, China between February and April 2020 were examined. Demographic, clinical, and laboratory data, and outcomes were compared between survivors and non-survivors COVID-19 patients, and between patients with high and low serum Syndecan-1 levels. The dynamics of serum Syndecan-1 levels were also analyzed. Results The levels of Syndecan-1 were significantly higher in non-survivor group compared with survivor group (median 1031.4 versus 504.0 ng/mL, P = 0.002), and the levels of thrombomodulin were not significantly different between these two groups (median 4534.0 versus 3780.0 ng/mL, P = 0.070). Kaplan–Meier survival analysis showed that the group with high Syndecan-1 levels had worse overall survival (log-rank test: P = 0.023). Patients with high Syndecan-1 levels also had significantly higher levels of thrombomodulin, interleukin-6, and tumor necrosis factor-α. Data on the dynamics of Syndecan-1 levels indicated much greater variations in non-survivors than survivors. Conclusions COVID-19 patients with high levels of Syndecan-1 develop more serious endothelial damage and inflammatory reactions, and have increased mortality. Syndecan-1 has potential for use as a marker for progression or severity of COVID-19. Protecting the glycocalyx from destruction is a potential treatment for COVID-19.Dong ZhangLiubing LiYu ChenJie MaYanli YangSurita AodengQiuju CuiKedi WenMeng XiaoJing XieYingchun XuYongzhe LiBMCarticleSyndecan-1Endothelial glycocalyxDegradationOutcomeCOVID-19Therapeutics. PharmacologyRM1-950BiochemistryQD415-436ENMolecular Medicine, Vol 27, Iss 1, Pp 1-12 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Syndecan-1 Endothelial glycocalyx Degradation Outcome COVID-19 Therapeutics. Pharmacology RM1-950 Biochemistry QD415-436 |
| spellingShingle |
Syndecan-1 Endothelial glycocalyx Degradation Outcome COVID-19 Therapeutics. Pharmacology RM1-950 Biochemistry QD415-436 Dong Zhang Liubing Li Yu Chen Jie Ma Yanli Yang Surita Aodeng Qiuju Cui Kedi Wen Meng Xiao Jing Xie Yingchun Xu Yongzhe Li Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 |
| description |
Abstract Background We investigated the feasibility of two biomarkers of endothelial damage (Syndecan-1 and thrombomodulin) in coronavirus disease 2019 (COVID-19), and their association with inflammation, coagulopathy, and mortality. Methods The records of 49 COVID-19 patients who were admitted to an intensive care unit (ICU) in Wuhan, China between February and April 2020 were examined. Demographic, clinical, and laboratory data, and outcomes were compared between survivors and non-survivors COVID-19 patients, and between patients with high and low serum Syndecan-1 levels. The dynamics of serum Syndecan-1 levels were also analyzed. Results The levels of Syndecan-1 were significantly higher in non-survivor group compared with survivor group (median 1031.4 versus 504.0 ng/mL, P = 0.002), and the levels of thrombomodulin were not significantly different between these two groups (median 4534.0 versus 3780.0 ng/mL, P = 0.070). Kaplan–Meier survival analysis showed that the group with high Syndecan-1 levels had worse overall survival (log-rank test: P = 0.023). Patients with high Syndecan-1 levels also had significantly higher levels of thrombomodulin, interleukin-6, and tumor necrosis factor-α. Data on the dynamics of Syndecan-1 levels indicated much greater variations in non-survivors than survivors. Conclusions COVID-19 patients with high levels of Syndecan-1 develop more serious endothelial damage and inflammatory reactions, and have increased mortality. Syndecan-1 has potential for use as a marker for progression or severity of COVID-19. Protecting the glycocalyx from destruction is a potential treatment for COVID-19. |
| format |
article |
| author |
Dong Zhang Liubing Li Yu Chen Jie Ma Yanli Yang Surita Aodeng Qiuju Cui Kedi Wen Meng Xiao Jing Xie Yingchun Xu Yongzhe Li |
| author_facet |
Dong Zhang Liubing Li Yu Chen Jie Ma Yanli Yang Surita Aodeng Qiuju Cui Kedi Wen Meng Xiao Jing Xie Yingchun Xu Yongzhe Li |
| author_sort |
Dong Zhang |
| title |
Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 |
| title_short |
Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 |
| title_full |
Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 |
| title_fullStr |
Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 |
| title_full_unstemmed |
Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 |
| title_sort |
syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an icu with covid-19 |
| publisher |
BMC |
| publishDate |
2021 |
| url |
https://doaj.org/article/e4b741f2f0814af9b22c301b2190d647 |
| work_keys_str_mv |
AT dongzhang syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT liubingli syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT yuchen syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT jiema syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT yanliyang syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT suritaaodeng syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT qiujucui syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT kediwen syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT mengxiao syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT jingxie syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT yingchunxu syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 AT yongzheli syndecan1anindicatorofendothelialglycocalyxdegradationpredictsoutcomeofpatientsadmittedtoanicuwithcovid19 |
| _version_ |
1718372225875181568 |